Literature DB >> 11835337

Mutation of bcl-x gene in non-Hodgkin's lymphoma.

Hiroki Yamaguchi1, Koiti Inokuchi, Miki Tarusawa, Kazuo Dan.   

Abstract

The bcl-x gene product has two forms, bcl-xl and bcl-xs. The bcl-xl form, similar to bcl-2, inhibits apoptosis. Reverse transcriptase-polymerase chain reaction/single-stranded conformation polymorphism (RT-PCR-SSCP) gel analysis was used to screen for mutations of the bcl-xl transcript of 50 non-Hodgkin's lymphoma (NHL) cases. One missense mutation in a patient with diffuse large B-cell lymphoma was found. Sequence analysis of this case showed that AGC (Ser) was mutated to GGC (Gly) in codon 154. An examination of mutation and/or polymorphism in born marrow samples of this case and 50 normal controls by the RT-PCR-SSCP method could not detect bandshifts. Mutation of the bcl-x gene in NHL has not been reported previously. There is a possibility that mutation of the bcl-x gene play a role in the tumorigenesis of NHL. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835337     DOI: 10.1002/ajh.10030

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.

Authors:  Hui Xiao; Hemant Kumar Bid; David Jou; Xiaojuan Wu; Wenying Yu; Chenglong Li; Peter J Houghton; Jiayuh Lin
Journal:  J Biol Chem       Date:  2014-10-13       Impact factor: 5.157

2.  STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.

Authors:  Li Lin; David Jou; Yina Wang; Haiyan Ma; Tianshu Liu; James Fuchs; Pui-Kai Li; Jiagao Lü; Chenglong Li; Jiayuh Lin
Journal:  Int J Oncol       Date:  2016-10-12       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.